VNRXVOLITIONRX LTD

NYSE volition.com


$ 0.86 $ -0.05 (-6.01 %)    

Monday, 29-Apr-2024 15:59:46 EDT
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 0.8588
$ 0.83
$ 0.85 x 100
$ 0.92 x 200
$ 0.83 - $ 0.88
$ 0.55 - $ 2.10
93,069
na
70.48M
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-15-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-22-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 02-20-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 03-13-2019 12-31-2018 10-K
22 11-07-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-10-2017 06-30-2017 10-Q
28 05-11-2017 03-31-2017 10-Q
29 03-10-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-13-2016 03-31-2016 10-Q
33 03-11-2016 12-31-2015 10-K
34 11-04-2015 09-30-2015 10-Q
35 08-11-2015 06-30-2015 10-Q
36 05-12-2015 03-31-2015 10-Q
37 03-18-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-01-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-overweight-on-volitionrx-maintains-25-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates VolitionRX (AMEX:VNRX) with a Overweight and maintains $2.5 price target.

 ef-hutton-maintains-buy-on-volitionrx-maintains-45-price-target

EF Hutton analyst Tim Moore maintains VolitionRX (AMEX:VNRX) with a Buy and maintains $4.5 price target.

 volitionrx-q4-eps-011-inline-sales-24397k-miss-45000k-estimate

VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 15.38...

 volitionrx-cash-and-cash-equivalents-as-of-december-31-2023-totaled-207m

Financial HighlightsCash and cash equivalents as of December 31, 2023, totaled approximately $20.7 million as compared to $10.9...

 earnings-scheduled-for-march-25-2024

Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on re...

 earnings-outlook-for-volitionrx
Earnings Outlook For VolitionRX
03/22/2024 14:01:49

 volition-issues-business-review-2023-outlining-its-key-highlights-from-the-past-year

VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, has issued a Business Review of 2023...

 why-trinity-place-holdings-shares-are-trading-higher-by-80-here-are-20-stocks-moving-premarket

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mor...

 ef-hutton-reiterates-buy-on-volitionrx-maintains-45-price-target

EF Hutton analyst Tim Moore reiterates VolitionRX (AMEX:VNRX) with a Buy and maintains $4.5 price target.

 reported-earlier-volitionrx-says-on-dec-29-received-13m-in-milestone-payments-from-heska-post-license-and-supply-deal-entered-into-on-march-28-2022

- SEC Filing  On December 29, 2023, VolitionRx Limited (the "Company")  received $13.0 million in milestone payments fr...

 volitionrx-secures-55m-in-belgium-regional-government-financing-from-wallonie-entreprendre

 VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, has closed on an aggregate of Euro ...

 io-biotech-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence ...

 ef-hutton-reiterates-buy-on-volitionrx-maintains-45-price-target

EF Hutton analyst Tim Moore reiterates VolitionRX (AMEX:VNRX) with a Buy and maintains $4.5 price target.

 ondas-holdings-and-2-other-stocks-under-1-insiders-are-buying

The Dow Jones closed higher by around 2 points on Friday. When insiders purchase or sell shares, it indicates their confidence ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION